Your browser doesn't support javascript.
loading
Potent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805.
Baffert, Fabienne; Régnier, Catherine H; De Pover, Alain; Pissot-Soldermann, Carole; Tavares, Gisele A; Blasco, Francesca; Brueggen, Josef; Chène, Patrick; Drueckes, Peter; Erdmann, Dirk; Furet, Pascal; Gerspacher, Marc; Lang, Marc; Ledieu, David; Nolan, Lynda; Ruetz, Stephan; Trappe, Joerg; Vangrevelinghe, Eric; Wartmann, Markus; Wyder, Lorenza; Hofmann, Francesco; Radimerski, Thomas.
Affiliation
  • Baffert F; Disease Area Oncology, Novartis Institutes for BioMedical Research, 4057 Basel, Switzerland.
Mol Cancer Ther ; 9(7): 1945-55, 2010 Jul.
Article in En | MEDLINE | ID: mdl-20587663
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Quinoxalines / Cell Proliferation / Janus Kinase 2 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2010 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polycythemia / Quinoxalines / Cell Proliferation / Janus Kinase 2 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2010 Document type: Article Affiliation country: